​

Alterity Therapeutics (ATHE) Stock Forecast, Price Target & Predictions

OverviewChart

ATHE Stock Rating

Alterity Therapeutics stock's rating consensus is Buy, based on 6 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 3 Buy (50.00%), 3 Hold (50.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 6 0 3 3 Strong Sell Sell Hold Buy Strong Buy

ATHE Price Target Upside V Benchmarks

TypeNameUpside
StockAlterity Therapeutics-
SectorHealthcare Stocks 23.68%
IndustryBiotech Stocks 64.77%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$4.59$4.59$4.59
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 25111--3
May, 25111--3
Apr, 25111--3
Mar, 25111--3
Feb, 25111--3
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Feb 03, 2025BenchmarkSpeculative BuyBuydowngrade
Sep 26, 2022BenchmarkSpeculative BuySpeculative Buyhold

Financial Forecast

EPS Forecast

$-7 $-6 $-5 $-4 $-3 $-2 $-1 $0 Jun 20 Jun 21 Jun 22 Jun 23 Jun 24 Jun 25 Jun 26 Jun 27 Jun 28 Jun 29
Jun 20Jun 21Jun 22Jun 23Jun 24Jun 25Jun 26Jun 27Jun 28Jun 29
Reported$-6.74$-5.41$-3.20-------
Avg Forecast$-3.92$-3.58$-3.04$-1.20$-1.66$-0.88$-0.66$-0.61$-1.02$-1.09
High Forecast$-3.92$-3.58$-3.04$-1.20$-1.66$-0.88-$-0.61$-1.02$-1.09
Low Forecast$-3.92$-3.58$-3.04$-1.20$-1.66$-0.88$-1.32$-0.61$-1.02$-1.09
Surprise %71.94%51.12%5.26%-------

Revenue Forecast

$0 $1M $2M $3M $4M $6M Jun 20 Jun 21 Jun 22 Jun 23 Jun 24 Jun 25 Jun 26 Jun 27 Jun 28 Jun 29
Jun 20Jun 21Jun 22Jun 23Jun 24Jun 25Jun 26Jun 27Jun 28Jun 29
Reported$411.57K$3.25M$3.54M-------
Avg Forecast$2.41M$2.77M$3.10M$3.04M$2.58M$5.07M$2.94M$1.81M$3.91M$3.88M
High Forecast$2.41M$2.77M$3.10M$3.04M$2.58M$5.07M$3.07M$1.81M$3.91M$3.88M
Low Forecast$2.41M$2.77M$3.10M$3.04M$2.58M$5.07M$2.81M$1.81M$3.91M$3.88M
Surprise %-82.93%17.49%14.16%-------

Net Income Forecast

$-25B $-20B $-15B $-10B $-5B $0 Jun 20 Jun 21 Jun 22 Jun 23 Jun 24 Jun 25 Jun 26 Jun 27 Jun 28 Jun 29
Jun 20Jun 21Jun 22Jun 23Jun 24Jun 25Jun 26Jun 27Jun 28Jun 29
Reported$-10.06M$-15.31M$-12.85M$-13.81M------
Avg Forecast$-23.83B$-21.76B$-18.51B$-4.36B$-6.04B$-3.20B$-2.41B$-2.23B$-3.72B$-3.98B
High Forecast$-23.83B$-21.76B$-18.51B$-4.36B$-6.04B$-3.20B$-8.04M$-2.23B$-3.72B$-3.98B
Low Forecast$-23.83B$-21.76B$-18.51B$-4.36B$-6.04B$-3.20B$-4.81B$-2.23B$-3.72B$-3.98B
Surprise %-99.96%-99.93%-99.93%-99.68%------

ATHE Forecast FAQ

Is Alterity Therapeutics stock a buy?

Alterity Therapeutics stock has a consensus rating of Buy, based on 6 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 3 Buy, 3 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Alterity Therapeutics is a favorable investment for most analysts.

What is Alterity Therapeutics's price target?

Alterity Therapeutics's price target, set by 6 Wall Street analysts, averages - over the next 12 months. The price target range spans from - at the low end to - at the high end, suggesting a potential 0% change from the previous closing price of $4.59.

How does Alterity Therapeutics stock forecast compare to its benchmarks?

Alterity Therapeutics's stock forecast shows a 0% downside, underperforming the average forecast for the healthcare stocks sector (23.68%) and underperforming the biotech stocks industry (64.77%).

What is the breakdown of analyst ratings for Alterity Therapeutics over the past three months?

  • June 2025: 33.33% Strong Buy, 33.33% Buy, 33.33% Hold, 0% Sell, 0% Strong Sell.
  • May 2025: 33.33% Strong Buy, 33.33% Buy, 33.33% Hold, 0% Sell, 0% Strong Sell.
  • April 2025: 33.33% Strong Buy, 33.33% Buy, 33.33% Hold, 0% Sell, 0% Strong Sell.

What is Alterity Therapeutics’s EPS forecast?

Alterity Therapeutics's average annual EPS forecast for its fiscal year ending in June 2024 is $-1.66, marking a 0% decrease from the reported $0 in 2023. Estimates for the following years are $-0.88 in 2025, $-0.66 in 2026, $-0.61 in 2027, $-1.02 in 2028, and $-1.09 in 2029.

What is Alterity Therapeutics’s revenue forecast?

Alterity Therapeutics's average annual revenue forecast for its fiscal year ending in June 2024 is $2.58M, reflecting a 0% decrease from the reported $0 in 2023. The forecast for 2025 is $5.07M, followed by $2.94M for 2026, $1.81M for 2027, $3.91M for 2028, and $3.88M for 2029.

What is Alterity Therapeutics’s net income forecast?

Alterity Therapeutics's net income forecast for the fiscal year ending in June 2024 stands at $-6.043B, representing an 43669.02% increase from the reported $-13.807M in 2023. Projections indicate $-3.199B in 2025, $-2.409B in 2026, $-2.234B in 2027, $-3.722B in 2028, and $-3.977B in 2029.